cartitude-1: cilta-cel improves hrqol for patients with myeloma
Published 3 years ago • 114 plays • Length 2:09Download video MP4
Download video MP3
Similar videos
-
1:25
cartitude-1: outcomes of patients with triple-class exposed multiple myeloma treated with cilta-cel
-
1:30
cartitude-1: promising initial results of cilta-cel for myeloma
-
1:38
cartitude-1 final results: pfs of cilta-cel in patients with heavily pre-treated r/r myeloma
-
2:25
cartitude-1 final results: cilta-cel in heavily pretreated patients with r/r myeloma
-
2:32
final results of cartitude-1: cilta-cel in heavily pretreated patients with r/r multiple myeloma
-
4:04
the future of myeloma treatment and the possibility of cure
-
18:33
car t-cell therapy: reprogramming the immune system to treat cancer | rob weinkove | tedxtauranga
-
9:25
mgus diagnosis: a step-by-step approach
-
2:17
cilta-cel: a paradigm shift in the treatment of multiple myeloma
-
4:21
cartitude-1: health-related qol with cilta-cel for myeloma
-
4:25
updated results from cartitude-1: phase 1b/2study of cilta-cel in pts with rr multiple myeloma
-
1:47
cilta-cel in earlier lines of therapy for r/r multiple myeloma
-
5:44
cilta-cel in r/r myeloma: preliminary results from cartitude-1
-
2:25
caritude-1: cilta-cel achieves deep and durable responses in r/r myeloma
-
1:26
cilta-cel vs. therapies from real-world clinical practice for triple-class exposed myeloma
-
1:07
updated results from cartitude-1
-
3:52
updated results (2 years post-lpi) in phase 1b/2 (cartitude-1) study of cilta-cel in rrmm patients
-
3:37
updated data from cartitude-1 and cartitude-2 studies testing cilta-cel in r/r multiple myeloma
-
2:08
comparison of the outcomes from cartitude-1 with a real-world external cohort
-
2:25
cartitude-5: vrd cilta-cel or rd in newly diagnosed multiple myeloma
-
3:15
cartitude update: patient expectations and experiences of cilta-cel in r/r myeloma